Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.540
+0.110 (4.53%)
Nov 22, 2024, 4:00 PM EST - Market closed

BDTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Selling, General & Admin
27.0627.1128.3930.0421.367.58
Upgrade
Research & Development
54.359.3564.4496.8348.2121.75
Upgrade
Operating Expenses
81.3686.4692.83126.8769.5729.33
Upgrade
Operating Income
-81.36-86.46-92.83-126.87-69.57-29.33
Upgrade
Interest Expense
-----0-
Upgrade
Interest & Investment Income
1.941.922.033.464.040.46
Upgrade
Earnings From Equity Investments
---2.25---
Upgrade
Currency Exchange Gain (Loss)
----000.01
Upgrade
Other Non Operating Income (Expenses)
4.83.270.18---6.39
Upgrade
EBT Excluding Unusual Items
-74.62-81.27-92.87-123.41-65.53-35.26
Upgrade
Gain (Loss) on Sale of Investments
1.52-1.17-0.54-2.19-1.73-
Upgrade
Gain (Loss) on Sale of Assets
--2.23---
Upgrade
Pretax Income
-73.1-82.44-91.17-125.6-67.25-35.26
Upgrade
Net Income
-73.1-82.44-91.17-125.6-67.25-35.26
Upgrade
Net Income to Common
-73.1-82.44-91.17-125.6-67.25-35.26
Upgrade
Shares Outstanding (Basic)
54443636332
Upgrade
Shares Outstanding (Diluted)
54443636332
Upgrade
Shares Change (YoY)
34.09%21.00%0.38%9.97%1485.31%2.83%
Upgrade
EPS (Basic)
-1.36-1.88-2.51-3.47-2.04-16.99
Upgrade
EPS (Diluted)
-1.36-1.88-2.51-3.47-2.05-16.99
Upgrade
Free Cash Flow
-61.2-66.75-85.27-102.86-52.29-24.7
Upgrade
Free Cash Flow Per Share
-1.14-1.52-2.35-2.84-1.59-11.90
Upgrade
EBITDA
-81.02-86.02-92.32-126.67-69.52-29.29
Upgrade
D&A For EBITDA
0.340.440.510.210.050.05
Upgrade
EBIT
-81.36-86.46-92.83-126.87-69.57-29.33
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.